Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're looking into Mounjaro in Sheffield, the core facts are straightforward: tirzepatide is a prescription-only weight-management medicine licensed in the UK for adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition. A prescriber must assess your suitability before any treatment begins — that is a legal requirement, not an optional step. Whether you explore this through a Sheffield GP, an NHS specialist service, or a regulated online pharmacy, the clinical gate is the same. What differs is speed, convenience, and what you pay. Tirzepatide's mechanism and trial evidence are covered separately if you want the full science first.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is usually the first fork. Mounjaro is available on the NHS in England under NICE guidance TA1026, but the criteria are strict and the rollout is phased. As of summer 2026, NHS tirzepatide is available to adults with a BMI of 40 or above who also have four or more qualifying conditions from a defined list, hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, and type 2 diabetes. A second cohort, covering BMI 35–39.9 with four or more of those conditions, opened in June 2026. Lower BMI thresholds apply for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds under NICE guidance. If you do qualify, your Sheffield GP practice may now prescribe under the 2026 QOF contract, though participation varies by practice. NHS patients also need to engage with wraparound diet and activity support as part of treatment. The full picture of what Mounjaro involves is worth reading before you approach your GP.
Private treatment has lower eligibility thresholds (BMI of 30 or above, or 27 or above with a relevant health condition) and no waiting list. A regulated online pharmacy can complete the consultation, prescriber review, and dispatch within a working day for people who don't qualify for NHS treatment yet, or who simply don't want to wait. The trade-off is cost, which is covered below.
Geography is essentially irrelevant for a regulated online pharmacy. The pharmacy holds a GPhC registration you can verify independently, nume's GPhC registration (9012878) is publicly searchable on the regulator's register. Treatment is dispensed from a UK-registered pharmacy and delivered by tracked courier. At nume, orders placed by 12pm Monday to Friday are dispatched the same day once a prescriber has reviewed and approved the consultation, and next-working-day DPD delivery reaches Sheffield reliably. The pen arrives in plain, unbranded packaging. Storage is straightforward: the KwikPen needs to stay refrigerated between 2°C and 8°C, most people keep it in the fridge door. It is worth reading about whether Mounjaro has a shelf life, and the time-limited room-temperature allowances covered in the Patient Information Leaflet, because those details matter before you travel or start.
The identity verification and live weight check that reputable online services require are completed before any prescription is issued. A GPhC-registered Independent Prescriber reads your consultation answers, not a triage algorithm. That clinical step is non-negotiable regardless of where in the country you live.
In the SURMOUNT-1 trial (involving 2,539 adults with obesity across multiple sites) participants on the highest tirzepatide dose achieved an average body-weight reduction of around 20–21% over 72 weeks, alongside a reduced-calorie diet and increased activity. A detailed breakdown of the tirzepatide efficacy data puts those numbers in context. The key word is average: individual results depend on adherence, dose reached, starting weight, diet changes, and activity. Clinical trials measure populations; your prescriber assesses you as an individual. NICE's own committee, in TA1026, noted that if less than 5% weight loss is achieved after six months at the highest tolerated dose, continuing the medicine should be reviewed.
Practically speaking, most people notice appetite changes from the early weeks, but meaningful weight loss takes months. Patience matters more than dose speed. Rushing titration in pursuit of faster results tends to increase side-effect burden without improving outcomes.
Private Mounjaro pricing in Sheffield is the same as anywhere else in England: you're buying from a UK pharmacy, not a local clinic. Since Eli Lilly raised UK list prices in September 2025, typical private prices range roughly £149 to £375 per month by dose and provider, as widely reported at the time. That range matters because a suspiciously low price is one of the clearest warning signs for counterfeit product. The MHRA has warned publicly about fake weight-loss pens sold online, and in October 2025 a site producing counterfeit tirzepatide was raided. Suspect sellers can be reported through the MHRA's Yellow Card scheme.
The question of cost versus value deserves a read before you compare headline prices, because what those prices include varies considerably. Some providers quote a pen price that excludes the consultation, prescription, and aftercare. nume's price includes everything: free consultation, prescriber review, treatment, and free next-working-day delivery, with no subscription. We are not the cheapest option, and that is a deliberate position. If you want to explore whether treatment is right for you, speak to our prescribers through a free consultation with no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.